Literature DB >> 17534396

Mechanism of saikosaponin-d in the regulation of rat mesangial cell proliferation and synthesis of extracellular matrix proteins.

Ning Zu1, Ping Li, Ning Li, Patrick Choy, Yuewen Gong.   

Abstract

Glomerulosclerosis is a common disorder in many types of chronic kidney diseases. Previous studies have shown that glomerular mesangial cells (MCs) play an important role in the pathogenesis of glomerulosclerosis. The ability of saikosaponin-d (SSd) to reduce the damage of kidney in progressive glomerulosclerosis has been demonstrated. In this study, the effects of saikosaponin-d on MC proliferation and synthesis of extracellular matrix proteins were investigated. Rat MCs were isolated from Wistar rats and cultured in Dulbecco's modified Eagle's medium. MCs were challenged with lipopolysacchorides and incubated with different concentrations of SSd. Cell proliferation and cytotoxicity were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), flow cytometry, and lactate dehydrogenase assays. Type IV collagen, fibronectin, and TGF-beta1 in the conditioned medium were measured. The expression of cyclin-dependent kinase 4, c-Jun, and c-Fos was determined by immunohistochemistry. At a concentration of 4 microg/mL or lower, SSd inhibited MC proliferation but did not cause cell death. SSd also inhibited lipopolysaccharide-induced secretion of type IV collagen, fibronectin, and TGF-beta1 in MCs. Additionally, SSd reduced the expression of CDK4, c-Jun, and c-Fos in MCs. We conclude that SSd inhibited MC proliferation and synthesis of extracullular matrix proteins through the downregulation of the CDK4, c-Jun, and c-Fos genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534396     DOI: 10.1139/O07-002

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  8 in total

1.  The theory of homogeny of liver and kidney in the treatment of kidney and liver fibrosis.

Authors:  Ping Li; Hao-Jun Zhang; Liu-Tao Zheng
Journal:  Chin J Integr Med       Date:  2012-03-30       Impact factor: 1.978

Review 2.  Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease.

Authors:  Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2008-12-13       Impact factor: 3.714

3.  Yi Qi Qing Re Gao-containing serum inhibits lipopolysaccharide-induced rat mesangial cell proliferation by suppressing the Wnt pathway and TGF-β1 expression.

Authors:  Liping Yang; Xueyan Sun; Yongli Zhan; Huijie Liu; Yumin Wen; Huimin Mao; X I Dong; Ping Li
Journal:  Exp Ther Med       Date:  2016-01-28       Impact factor: 2.447

Review 4.  Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Ramaswamy Kannappan; Bharat B Aggarwal
Journal:  Toxins (Basel)       Date:  2010-10-22       Impact factor: 4.546

5.  Traditional Chinese Medicine in Treating IgA Nephropathy: From Basic Science to Clinical Research.

Authors:  Xin-Hui Wang; Rui Lang; Ying Liang; Qin Zeng; Nan Chen; Ren-Huan Yu
Journal:  J Transl Int Med       Date:  2021-09-28

Review 6.  Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases.

Authors:  Yifei Zhong; Yueyi Deng; Yiping Chen; Peter Y Chuang; John Cijiang He
Journal:  Kidney Int       Date:  2013-07-17       Impact factor: 10.612

7.  Effects of pyrrolidine dithiocarbamate on proliferation and nuclear factor-κB activity in autosomal dominant polycystic kidney disease cells.

Authors:  Michelle H T Ta; David Liuwantara; Gopala K Rangan
Journal:  BMC Nephrol       Date:  2015-12-15       Impact factor: 2.388

8.  In vitro and in vivo study of the expression of the Syk/Ras/c‑Fos pathway in chronic glomerulonephritis.

Authors:  Jiarong Gao; Liangbing Wei; Junmei Song; Hui Jiang; Yachen Gao; Xi Wu; Shuangzhi Xu
Journal:  Mol Med Rep       Date:  2018-08-03       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.